Researchers have suggested Zika may have adverse effects on the cardiovascular system based on new data from a small case report; an association which has previously been unreported.
Browsing: Viral > Zika
Researchers have analyzed the clinical characteristics of Zika infection in Canadian travelers returning from the Americas, discovering that severe complications might be more common than previously estimated.
The National Institutes of Health (MD, USA) have begun a Phase I clinical trial examining a vaccine intended to provide broad protection against a range of mosquito-borne diseases by targeting the insect’s saliva.
Researchers have utilized a novel mouse model to demonstrate that Zika infection during early pregnancy could lead to higher risk of miscarriage in addition to thin brain tissue and brain inflammation in infants.
Researchers have uncovered a mechanism utilized by Zika virus to cross the placental barrier; this has provided an insight into the virus’ ability to cause birth defects such as microcephaly
Researchers have pioneered an mRNA-based vaccine against Zika that has demonstrated promising results in pre-clinical trials on mice and monkeys.
In this review the author looks at the progress of vaccine development towards mosquito-borne viral diseases, such as Zika and chikungunya.